Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Corcept Therapeutics Shares Outstanding 2011-2025 | CORT

Corcept Therapeutics shares outstanding history from 2011 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Corcept Therapeutics shares outstanding for the quarter ending June 30, 2025 were 0.120B, a 8.31% increase year-over-year.
  • Corcept Therapeutics 2024 shares outstanding were 0.113B, a 1.56% increase from 2023.
  • Corcept Therapeutics 2023 shares outstanding were 0.112B, a 3.64% decline from 2022.
  • Corcept Therapeutics 2022 shares outstanding were 0.116B, a 7.94% decline from 2021.
Corcept Therapeutics Annual Shares Outstanding
(Millions of Shares)
2024 113
2023 112
2022 116
2021 126
2020 124
2019 123
2018 127
2017 125
2016 116
2015 107
2014 101
2013 100
2012 93
2011 83
2010 68
Corcept Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2025-06-30 120
2025-03-31 120
2024-12-31 113
2024-09-30 114
2024-06-30 111
2024-03-31 110
2023-12-31 112
2023-09-30 111
2023-06-30 110
2023-03-31 115
2022-12-31 116
2022-09-30 117
2022-06-30 115
2022-03-31 115
2021-12-31 126
2021-09-30 125
2021-06-30 127
2021-03-31 130
2020-12-31 124
2020-09-30 124
2020-06-30 123
2020-03-31 122
2019-12-31 123
2019-09-30 122
2019-06-30 122
2019-03-31 124
2018-12-31 127
2018-09-30 126
2018-06-30 128
2018-03-31 128
2017-12-31 125
2017-09-30 126
2017-06-30 123
2017-03-31 121
2016-12-31 116
2016-09-30 116
2016-06-30 115
2016-03-31 110
2015-12-31 107
2015-09-30 108
2015-06-30 108
2015-03-31 102
2014-12-31 101
2014-09-30 101
2014-06-30 101
2014-03-31 101
2013-12-31 100
2013-09-30 100
2013-06-30 100
2013-03-31 100
2012-12-31 93
2012-09-30 99
2012-06-30 89
2012-03-31 84
2011-12-31 83
2011-09-30 84
2011-06-30 84
2011-03-31 81
2010-12-31 68
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.685B $0.675B
Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone), is approved for the once-daily oral treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, suffering from type II diabetes or glucose intolerance and who have failed surgery or are not suitable for surgery.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $74.015B 28.11
Zoetis (ZTS) United States $52.689B 18.86
Takeda Pharmaceutical (TAK) Japan $43.402B 8.86
Daiichi Sankyo, - (DSNKY) Japan $41.941B 20.89
BeOne Medicines - (ONC) Switzerland $36.448B 193.23
Sandoz Group AG (SDZNY) Switzerland $29.586B 0.00
United Therapeutics (UTHR) United States $19.548B 17.20
Merck (MKKGY) Germany $16.433B 10.69
Neurocrine Biosciences (NBIX) United States $15.434B 37.03
Shionogi (SGIOY) Japan $14.445B 13.27
Summit Therapeutics (SMMT) United States $14.228B 0.00
Ionis Pharmaceuticals (IONS) United States $12.002B 0.00
IPSEN (IPSEY) France $11.841B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.096B 0.00
Orion OYJ (ORINY) Finland $8.793B 25.12
Eisai (ESAIY) $8.166B 0.00
Stevanato Group S.p.A (STVN) Italy $7.392B 41.37
Grifols, S.A (GRFS) Spain $5.748B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.549B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.173B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.096B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.662B 17.40
Centessa Pharmaceuticals (CNTA) United Kingdom $3.058B 0.00
Hypermarcas (HYPMY) Brazil $2.899B 21.80
Dyne Therapeutics (DYN) United States $2.600B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.580B 8.23
Soleno Therapeutics (SLNO) United States $2.339B 0.00
Ocular Therapeutix (OCUL) United States $2.265B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.839B 21.80
Avadel Pharmaceuticals (AVDL) Ireland $1.817B 0.00
Guardian Pharmacy Services (GRDN) United States $1.804B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.480B 87.88
Ardelyx (ARDX) United States $1.373B 0.00
Collegium Pharmaceutical (COLL) United States $1.281B 6.36
Harrow (HROW) United States $1.274B 0.00
Xeris Biopharma Holdings (XERS) United States $1.245B 0.00
Oruka Therapeutics (ORKA) United States $1.175B 0.00
Evotec AG (EVO) Germany $1.174B 0.00
Relay Therapeutics (RLAY) United States $1.126B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.111B 0.00
Enliven Therapeutics (ELVN) United States $1.084B 0.00
Nektar Therapeutics (NKTR) United States $1.048B 0.00
Xencor (XNCR) United States $1.000B 0.00
Cronos Group (CRON) Canada $0.946B 0.00
ProKidney (PROK) United States $0.827B 0.00
ARS Pharmaceuticals (SPRY) United States $0.810B 0.00
Theravance Biopharma (TBPH) United States $0.749B 61.96
Aquestive Therapeutics (AQST) United States $0.748B 0.00
Savara (SVRA) United States $0.688B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.656B 5.85
Elite Pharmaceuticals (ELTP) United States $0.645B 0.00
Bioventus (BVS) United States $0.618B 12.68
Siga Technologies (SIGA) United States $0.585B 8.01
KalVista Pharmaceuticals (KALV) United States $0.550B 0.00
Akebia Therapeutics (AKBA) United States $0.533B 0.00
Zevra Therapeutics (ZVRA) United States $0.512B 0.00
4D Molecular Therapeutics (FDMT) United States $0.510B 0.00
Esperion Therapeutics (ESPR) United States $0.504B 0.00
Organogenesis (ORGO) United States $0.493B 0.00
Lexeo Therapeutics (LXEO) United States $0.455B 0.00
Galectin Therapeutics (GALT) United States $0.360B 0.00
USANA Health Sciences (USNA) United States $0.350B 9.78
Altimmune (ALT) United States $0.348B 0.00
Lyell Immunopharma (LYEL) United States $0.344B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.333B 51.25
Korro Bio (KRRO) United States $0.306B 0.00
Aldeyra Therapeutics (ALDX) United States $0.289B 0.00
Larimar Therapeutics (LRMR) United States $0.287B 0.00
Pyxis Oncology (PYXS) United States $0.252B 0.00
Aclaris Therapeutics (ACRS) United States $0.246B 0.00
Achieve Life Sciences (ACHV) Canada $0.242B 0.00
Nature's Sunshine Products (NATR) United States $0.242B 14.30
Journey Medical (DERM) United States $0.242B 0.00
AleAnna (ANNA) United States $0.219B 0.00
Avalo Therapeutics (AVTX) United States $0.203B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
MediWound (MDWD) Israel $0.200B 0.00
OmniAb (OABI) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.166B 0.00
Protara Therapeutics (TARA) United States $0.166B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.153B 0.00
Cassava Sciences (SAVA) United States $0.143B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Incannex Healthcare (IXHL) Australia $0.127B 0.00
Inhibikase Therapeutics (IKT) United States $0.111B 0.00
Surrozen (SRZN) United States $0.107B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Context Therapeutics (CNTX) United States $0.098B 0.00
Champions Oncology (CSBR) United States $0.095B 34.40
Vivani Medical (VANI) United States $0.093B 0.00
Avita Medical (RCEL) United States $0.091B 0.00
VAXART, INC (VXRT) United States $0.087B 0.00
Relmada Therapeutics (RLMD) United States $0.087B 0.00
Metagenomi (MGX) United States $0.083B 0.00
Unicycive Therapeutics (UNCY) United States $0.079B 0.00
Prelude Therapeutics (PRLD) United States $0.076B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.073B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.071B 0.00
Gain Therapeutics (GANX) United States $0.068B 0.00
Nutriband (NTRB) United States $0.067B 0.00
PMV Pharmaceuticals (PMVP) United States $0.066B 0.00
Lite Strategy (LITS) United States $0.066B 0.00
Acrivon Therapeutics (ACRV) United States $0.063B 0.00
Wellgistics Health (WGRX) United States $0.062B 0.00
PolyPid (PYPD) Israel $0.060B 0.00
BioNxt Solutions (BNXTF) Canada $0.060B 0.00
Fractyl Health (GUTS) United States $0.055B 0.00
Talphera (TLPH) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.053B 0.00
Plus Therapeutics (PSTV) United States $0.051B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.046B 0.00
Karyopharm Therapeutics (KPTI) United States $0.045B 0.00
FibroGen (FGEN) United States $0.044B 0.00
Telomir Pharmaceuticals (TELO) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Inotiv (NOTV) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Liminatus Pharma (LIMN) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.034B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.033B 27.38
Iterum Therapeutics (ITRM) Ireland $0.028B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.021B 0.00
Vyome Holdings (HIND) United States $0.021B 0.00
Mangoceuticals (MGRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Heatwurx (PCSA) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.02
Lipocine (LPCN) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
NewcelX (NCEL) Switzerland $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 16.26
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00